Compounds > cetylpyridinium chloride anhydrous
Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Liver Steatosis

cetylpyridinium chloride anhydrous has been researched along with Liver Steatosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alzaid, F; Burcelin, R; Callebert, J; Cardellini, M; Chajadine, M; Dairou, J; Denis, RGP; Esposito, B; Federici, M; Fernandez-Real, JM; Haddad, Y; Jegou, S; Launay, JM; Laurans, L; Luquet, SH; Mallat, Z; McQuitty, C; Metghalchi, S; Moreno-Navarrete, JM; Sokol, H; Sovran, B; Straub, M; Taleb, S; Tavitian, B; Tedgui, A; Venteclef, N; Viel, T1
Baek, KH; Kang, MI; Kim, MK; Kim, SW; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ1
Bartelt, A; Buettner, C; Buurman, WA; Eissing, L; Greve, JW; Heeren, J; Knippschild, U; Pinnschmidt, HO; Rensen, SS; Scheja, L; Scherer, T; Tödter, K; Wolf, AM1
Finkelstein, J; Heemels, MT; Shadan, S; Weiss, U1
Alfany-Fernandez, I; Bintanel-Morcillo, M; Brosnihan, KB; Casillas-Ramirez, A; Ferrario, CM; Peralta, C; Rimola, A; Rodés, J; Roselló-Catafau, J; Serafin, A1
Baccan, GC; Marcos, A; Nova, E; Veses, A; Zapatera, B1
Blomme, B; Caron, S; Colle, I; Coulon, S; De Munter, S; Francque, S; Geerts, A; Heindryckx, F; Prawitt, J; Staels, B; Van Gaal, L; Van Vlierberghe, H; Verrijken, A1
Bergholm, R; Eriksson, P; Fisher, RM; Häkkinen, AM; Hamsten, A; Kolak, M; Lindell, M; Makkonen, J; Oresic, M; Rissanen, A; Velagapudi, VR; Wågsäter, D; Westerbacka, J; Yetukuri, L; Yki-Järvinen, H1

Reviews

1 review(s) available for cetylpyridinium chloride anhydrous and Liver Steatosis

ArticleYear
Potential health benefits of moderate alcohol consumption: current perspectives in research.
    The Proceedings of the Nutrition Society, 2012, Volume: 71, Issue:2

    Topics: Alcohol Drinking; Animals; Cardiovascular Diseases; Cause of Death; Ethanol; Fatty Liver; Health; Humans; Immune System; Inflammation; Insulin Resistance; Neoplasms; Non-alcoholic Fatty Liver Disease

2012

Other Studies

7 other study(ies) available for cetylpyridinium chloride anhydrous and Liver Steatosis

ArticleYear
Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health.
    Nature medicine, 2018, Volume: 24, Issue:8

    Topics: Animals; Diabetes Mellitus, Type 2; Fatty Liver; Gastrointestinal Microbiome; Health; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Insulin Resistance; Interleukin-22; Interleukins; Intestines; Kynurenine; Lipopolysaccharides; Male; Mice, Inbred C57BL; Obesity; Principal Component Analysis; Tryptophan

2018
High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome.
    Endocrine journal, 2013, Volume: 60, Issue:6

    Topics: Adult; Aged; Calcifediol; Cross-Sectional Studies; Fatty Liver; Health; Humans; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Republic of Korea; Risk Factors; Young Adult

2013
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
    Nature communications, 2013, Volume: 4

    Topics: Adiposity; Adult; Bariatric Surgery; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Body Mass Index; Fatty Acid Synthases; Fatty Acids; Fatty Liver; Female; Gene Dosage; Gene Expression Regulation; Glucose Transporter Type 4; Health; Humans; Insulin Resistance; Intra-Abdominal Fat; Lipogenesis; Liver; Male; Middle Aged; Obesity; Risk Factors; RNA, Messenger; Subcutaneous Fat; Tumor Necrosis Factor-alpha

2013
Lipids in health and disease.
    Nature, 2014, Jun-05, Volume: 510, Issue:7503

    Topics: Adipose Tissue; Fatty Acids, Omega-3; Fatty Liver; Health; Humans; Lipid Metabolism; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Sphingolipids

2014
Therapeutic targets in liver transplantation: angiotensin II in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009, Volume: 9, Issue:3

    Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Apoptosis; Fatty Liver; Graft Survival; Health; Liver Transplantation; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Rats; Receptors, Angiotensin

2009
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
    Cytokine, 2012, Volume: 59, Issue:2

    Topics: Adult; Angiogenesis Inducing Agents; Biopsy; Case-Control Studies; Fatty Liver; Female; Gene Expression Regulation; Health; Humans; Inflammation; Interleukin-6; Linear Models; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Young Adult

2012
Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.
    Diabetes, 2007, Volume: 56, Issue:8

    Topics: Adipose Tissue; Adolescent; Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood Cell Count; Cell Size; Ceramides; Cholesterol, HDL; Cytokines; Fasting; Fatty Liver; Female; Gene Expression Regulation; Health; Humans; Immunohistochemistry; Inflammation; Insulin; Macrophages; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; RNA, Messenger; Triglycerides

2007